article thumbnail

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs. “In Contact us: Start the discussion. US Digital Therapeutics Growth Opportunities. Contact: Mariana Fernandez.

article thumbnail

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs. “In Contact us: Start the discussion. US Digital Therapeutics Growth Opportunities. Contact: Mariana Fernandez.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Strengthening cybersecurity in life sciences with IBM and AWS

IBM Business Partners

Cloud is transforming the way life sciences organizations are doing business. Leading life science companies are leveraging cloud for innovation around operational, revenue and business models. The role of AWS and cloud security in life sciences However, with greater power comes great responsibility.

article thumbnail

NetApp Applauded by Frost & Sullivan for Addressing Complex and Constantly Evolving Healthcare and Life Sciences Challenges with its Cloud Services

Frost & Sullivan

NetApp brings clear value for payers, healthcare providers, and life sciences companies while ensuring the best outcomes through its customer-centered and data-centric approach. NetApp optimizes workloads and collaborations in a hybrid multi-cloud environment to enable flexibility and consistency in data movement.

article thumbnail

Leveraging generative AI on AWS to transform life sciences

IBM Business Partners

Life sciences industry is beginning to take notice and aims to leapfrog the technological advances. Life sciences industry has—for decades now—moved from the traditional discovery-based drug development to target market-based drug development paradigm. Why IBM Consulting for generative AI on AWS?

article thumbnail

8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021

Frost & Sullivan

To help companies identify new avenues for top-line growth and plan for a more fruitful 2021, Frost & Sullivan’s team of industry experts have compiled a complimentary insight: Top 8 Growth Opportunities in the Healthcare and Life Sciences Industry for 2021 – What You Need to Know Now. Contact: Mariana Fernandez.

article thumbnail

Key Growth Opportunities in Life Science Instrumentation and Lab Automation

Frost & Sullivan

The life science instrumentation and research tools industry is poised for consistent growth through 2029, driven by innovations in automation, software, and integrated solutions. What is driving growth in the Life Science Instrumentation and Research Tools Industry? Download now for comprehensive perspectives! <Download